Center-Authored Papers

Filters: Author is Mwatha, Anthony  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Read JS, Mwatha A, Richardson BA, Valentine M, Emel L, Manji K, Hoffman I, Sharma U, Goldenberg RL, Taha TE.  2009.  Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024.. Journal of acquired immune deficiency syndromes (1999). 51(3):317-22. Abstract
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K et al..  2009.  Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.. Pediatrics. 124(1):e137-44. Abstract
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere J-F, Domingo M-C, Piret J, Tsague L et al..  2009.  A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.. Contraception. 80(5):484-92. Abstract
2010
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Domingo M-C, Giguère J-F, Piret J, Mwatha A et al..  2010.  A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.. Contraception. 81(1):79-85. Abstract
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson BJ et al..  2010.  Analysis of HIV diversity using a high-resolution melting assay.. AIDS research and human retroviruses. 26(8):913-8. Abstract
Church JD, Huang W, Mwatha A, Musoke P, Jackson BJ, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C et al..  2010.  Analysis of HIV tropism in ugandan infants.. Current HIV research. 8(7):498-503. Abstract
2012
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K et al..  2012.  Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants.. The Pediatric infectious disease journal. Abstract
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
2013
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L et al..  2013.  Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Allen M, Jackson BJ, Fowler MG, Guay LA.  2013.  Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival.. Journal of acquired immune deficiency syndromes (1999). 64(5):464-71. Abstract
Administration, Intravaginal
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Domingo M-C, Giguère J-F, Piret J, Mwatha A et al..  2010.  A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.. Contraception. 81(1):79-85. Abstract
Administration, Oral
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
Adolescent
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Domingo M-C, Giguère J-F, Piret J, Mwatha A et al..  2010.  A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.. Contraception. 81(1):79-85. Abstract
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere J-F, Domingo M-C, Piret J, Tsague L et al..  2009.  A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.. Contraception. 80(5):484-92. Abstract
Adult
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K et al..  2009.  Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.. Pediatrics. 124(1):e137-44. Abstract
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Domingo M-C, Giguère J-F, Piret J, Mwatha A et al..  2010.  A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.. Contraception. 81(1):79-85. Abstract
Mwinga K, Vermund SH, Chen YQ, Mwatha A, Read JS, Urassa W, Carpenetti N, Valentine M, Goldenberg RL.  2009.  Selected hematologic and biochemical measurements in African HIV-infected and uninfected pregnant women and their infants: the HIV Prevention Trials Network 024 protocol.. BMC pediatrics. 9:49. Abstract
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Giguere J-F, Domingo M-C, Piret J, Tsague L et al..  2009.  A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.. Contraception. 80(5):484-92. Abstract
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
Africa
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K et al..  2009.  Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.. Pediatrics. 124(1):e137-44. Abstract
Africa South of the Sahara
Read JS, Mwatha A, Richardson BA, Valentine M, Emel L, Manji K, Hoffman I, Sharma U, Goldenberg RL, Taha TE.  2009.  Primary HIV-1 infection among infants in sub-Saharan Africa: HPTN 024.. Journal of acquired immune deficiency syndromes (1999). 51(3):317-22. Abstract
Africa South of the Sahara Anti-HIV Agents
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
Anti-Bacterial Agents
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K et al..  2009.  Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa.. Pediatrics. 124(1):e137-44. Abstract
Anti-HIV Agents
Mbopi-Keou F-X, Trottier S, Omar RF, Nkele NN, Fokoua S, Mbu ER, Domingo M-C, Giguère J-F, Piret J, Mwatha A et al..  2010.  A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.. Contraception. 81(1):79-85. Abstract